BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23237280)

  • 1. [Indolent lymphoma of the ear].
    Valois A; Bastien C; Granel-Broca F; Cuny JF; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2012 Dec; 139(12):818-23. PubMed ID: 23237280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases.
    Zeng W; Nava VE; Cohen P; Ozdemirli M
    J Cutan Pathol; 2012 Jul; 39(7):696-700. PubMed ID: 22612273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolent CD8+ lymphoid proliferation of the ear: report of two cases and review of the literature.
    Swick BL; Baum CL; Venkat AP; Liu V
    J Cutan Pathol; 2011 Feb; 38(2):209-15. PubMed ID: 21083681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indolent CD8+ lymphoid proliferation on the nose].
    Milley S; Bories N; Balme B; Thomas L; Dalle S
    Ann Dermatol Venereol; 2012 Dec; 139(12):812-7. PubMed ID: 23237279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrafacial indolent CD8-positive cutaneous lymphoid proliferation with unusual symmetrical presentation involving both feet.
    Wobser M; Petrella T; Kneitz H; Kerstan A; Goebeler M; Rosenwald A; Geissinger E
    J Cutan Pathol; 2013 Nov; 40(11):955-61. PubMed ID: 24102688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?
    Petrella T; Maubec E; Cornillet-Lefebvre P; Willemze R; Pluot M; Durlach A; Marinho E; Benhamou JL; Jansen P; Robson A; Grange F
    Am J Surg Pathol; 2007 Dec; 31(12):1887-92. PubMed ID: 18043044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous aggressive epidermotropic CD8 positive cytotoxic T-cell lymphoma of the ear.
    Fika Z; Karkos PD; Badran K; Williams RE
    J Laryngol Otol; 2007 May; 121(5):503-5. PubMed ID: 17166330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features.
    Greenblatt D; Ally M; Child F; Scarisbrick J; Whittaker S; Morris S; Calonje E; Petrella T; Robson A
    J Cutan Pathol; 2013 Feb; 40(2):248-58. PubMed ID: 23189944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?
    Beltraminelli H; Müllegger R; Cerroni L
    J Cutan Pathol; 2010 Jan; 37(1):81-4. PubMed ID: 19602068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-/medium-sized pleomorphic T-cell lymphoma or a distinct entity?
    Suchak R; O'Connor S; McNamara C; Robson A
    J Cutan Pathol; 2010 Sep; 37(9):977-81. PubMed ID: 19891656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD4 positive small/medium T-cell lymphoma with high proliferation index and CD30-positive large lymphoid cells.
    Zhang L; Shao H
    J Cutan Pathol; 2013 Aug; 40(8):720-4. PubMed ID: 23672694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter case series of indolent small/medium-sized CD8+ lymphoid proliferations with predilection for the ear and face.
    Li JY; Guitart J; Pulitzer MP; Subtil A; Sundram U; Kim Y; Deonizio J; Myskowski PL; Moskowitz A; Horwitz S; Querfeld C
    Am J Dermatopathol; 2014 May; 36(5):402-8. PubMed ID: 24394306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
    Wang L; Gao T; Wang G
    J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
    Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
    J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCR-γ expression in primary cutaneous T-cell lymphomas.
    Rodríguez-Pinilla SM; Ortiz-Romero PL; Monsalvez V; Tomás IE; Almagro M; Sevilla A; Camacho G; Longo MI; Pulpillo Á; Diaz-Pérez JA; Montes-Moreno S; Castro Y; Echevarría B; Trébol I; Gonzalez C; Sánchez L; Otín AP; Requena L; Rodríguez-Peralto JL; Cerroni L; Piris MÁ
    Am J Surg Pathol; 2013 Mar; 37(3):375-84. PubMed ID: 23348211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolent CD8+ lymphoid proliferation of the face with eyelid involvement.
    Hagen JW; Magro CM
    Am J Dermatopathol; 2014 Feb; 36(2):137-41. PubMed ID: 24556898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
    Marzano AV; Ghislanzoni M; Gianelli U; Caputo R; Alessi E; Berti E
    Dermatology; 2005; 211(3):281-5. PubMed ID: 16205076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.